Article Versions Notes

Pfeiffer A, Di Leo L, Bechmann MB, Nawabi M, Ambjørner S, Ardeshir-Larijani D, Colstrup LT, Borchert SV, Saaby L, Brodin B, et al. Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer. International Journal of Molecular Sciences. 2025; 26(8):3790. https://doi.org/10.3390/ijms26083790

Pfeiffer, Anamarija, Luca Di Leo, Marc Baker Bechmann, Mubeen Nawabi, Sophie Ambjørner, Diba Ardeshir-Larijani, Louise Thybo Colstrup, Signe Vedel Borchert, Lasse Saaby, Birger Brodin, and et al. 2025. "Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer" International Journal of Molecular Sciences 26, no. 8: 3790. https://doi.org/10.3390/ijms26083790

Pfeiffer, A., Di Leo, L., Bechmann, M. B., Nawabi, M., Ambjørner, S., Ardeshir-Larijani, D., Colstrup, L. T., Borchert, S. V., Saaby, L., Brodin, B., Gajhede, M., Lund, X. L., Čečková, M., Brünner, N., & Stenvang, J. (2025). Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer. International Journal of Molecular Sciences, 26(8), 3790. https://doi.org/10.3390/ijms26083790